Cystinuria Treatment Market: Introduction
Cystinuria is a rare autosomal recessive metabolic disease causing defective transepithelial amino acid transport in the kidneys. Cystine dissolves and returns to the bloodstream after entering the kidneys. People with cystinuria have a genetic defect that interferes with this process. As a result, cystine builds up in urine and forms crystals or stones.
Read Report Overview - https://www.transparencymarketresearch.com/cystinuria-treatmentmarket.html Key Drivers and Restraints of Global Cystinuria Treatment Market
High demand for disease specific novel treatment is a major driver of the global cystinuria treatment market. Cystinuria is rare disease; however, pharmaceutical companies are continuously innovating new treatment methods and drug class for cystinuria treatment. In July 2019, Retrophin announced the FDA approval of THIOLA EC (tiopronin) 100mg and 300mg tablets for the treatment of cystinuria. However, limited funding and operating revenue for research & development on targeted therapies for cystinuria hamper the growth of the global market
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php? flag=B&rep_id=77191 Penicillamine to Dominate Global Cystinuria Treatment Market
In terms of drug treatment, the global cystinuria treatment market can be classified into captopril, tiopronin, penicillamine, and others Penicillamine is the first-generation chelating agent, which mixes with cystine to form a soluble disulfide complex, thereby preventing stone formation and possibly even dissolving existing cystine stones. In May 2019, Amerigen Pharmaceuticals Limited received the U.S. FDA approval for Penicillamine Capsules USP 250 mg.
Online Pharmacies Segment to Witness Significant Growth
Based on distribution channel, the global cystinuria treatment market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies The retail pharmacies segment accounted for the largest share of the global cystinuria treatment market in 2019. However, the online pharmacies segment is expected to grow at a rapid pace from 2020 to 2030. Increase in popularity of online pharmacies for obtaining prescribed drugs and steady adoption of this distribution channel by customers are factors fueling the growth of the segment
Request for Analysis of COVID-19 Impact on Cystinuria Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77191 North America to Dominate Global Cystinuria Treatment Market
In terms of region, the global cystinuria treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa